Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 5:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1633–1656 of 7,897 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Hepatocellular Carcinoma, HCC
Interventions: Nivolumab, Ipilimumab, Cabozantinib, Transarterial Chemoembolization; Drug · Procedure
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Orange, California

Conditions: Posttraumatic Stress Disorder, Trauma
Interventions: Visuospatial Task (VST), Word Association Task (WAT); Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Loneliness, Social Isolation, Depression
Interventions: Phone Call; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: HIV Dementia, HIV-Associated Cognitive Motor Complex
Interventions: Insulin, intranasal, Placebo, intranasal; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 69 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Attention, Substance Use
Interventions: Attentional Bias Retraining (ABR), Control Training; Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
Interventions: SELUTION SLR™ DEB 014, Plain (Uncoated) Balloon Angioplasty (PTA); Device
Lead sponsor: M.A. Med Alliance S.A.; Industry
Eligibility: 18 Years and older
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 30
States / cities: Chandler, Arizona • Jonesboro, Arkansas • Little Rock, Arkansas + 26 more

Conditions: Cerebral Palsy, Neuromuscular Diseases, Neurodevelopment Treatment
Interventions: Therapy; Behavioral
Lead sponsor: MultiCare Health System Research Institute; Other
Eligibility: 2 Years to 15 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Puyallup, Washington

Conditions: Atrial Fibrillation
Interventions: Ionic Calcium, Calcium Carbonate; Dietary Supplement
Lead sponsor: National University of Natural Medicine; Other
Eligibility: 55 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Hepatocellular Carcinoma
Interventions: Non-Interventional Study; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 730 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: MPS IIIA, Sanfilippo Syndrome, Sanfilippo A, Mucopolysaccharidosis III
Interventions: UX111, Prophylactic Immunomodulatory (IM) Therapy, Optimized Prophylactic IM Therapy, Adjuvant IM Therapy; Biological · Drug
Lead sponsor: Ultragenyx Pharmaceutical Inc; Industry
Eligibility: Not listed
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2029
U.S. locations: 2
States / cities: Columbus, Ohio • Pittsburgh, Pennsylvania

Conditions: Diabetic Nephropathies, Kidney Diseases, Renal Insufficiency, Chronic, Diabetes Mellitus, Type 2
Interventions: Sodium-glucose cotransporter 2 inhibitors (SGLT2i), Renin-angiotensin-aldosterone system blockade, Glucagon-like peptide-1 receptor agonists (GLP 1 RA), Mineralocorticoid Receptor Antagonists(MRAs); Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Illness, Hematologic Malignancy, Bone Marrow Transplant Infection, Oncology, Sickle Cell Disease
Interventions: Guided Imagery, Virtual Reality; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 8 Years to 25 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Milwaukee, Wisconsin • Wauwatosa, Wisconsin

Conditions: Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI), Postoperative Pain
Interventions: Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Peri-implant Alveolar Bone Thickness
Interventions: DFDBA + Bio-Gide Membrane, Non-FDBA; Biological · Other
Lead sponsor: Creighton University; Other
Eligibility: 21 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Degenerative Disc Disease
Interventions: Anterior Cervical Discectomy and Fusion, Posterior Cervical Stabilization System (PCSS); Procedure · Device
Lead sponsor: Providence Medical Technology, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 17
States / cities: Phoenix, Arizona • Encinitas, California • Los Gatos, California + 14 more

Conditions: Hematopoietic Neoplasm
Interventions: Dietary intake -Food Frequency Questionnaire, Receptivity to Participating in Diet Interventions; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Venous Thromboembolism
Interventions: Photoacoustic flow cytometry device; Device
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Achalasia
Interventions: Achalasia subjects; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Breast Cancer, Neutropenia
Interventions: F-627, Placebo; Drug
Lead sponsor: EVIVE Biotechnology; Industry
Eligibility: 18 Years to 74 Years · Female only
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Diabetes
Interventions: Continuous Glucose Monitoring System (CGMS), Food log; Device · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Cancer
Interventions: Activity Monitor, Interactive Website, Educational Materials; Behavioral
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 11 Years to 14 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Diet Quality, Metabolic Health, Cognitive Function, Exercise Response
Interventions: Standardized Moderate-Intensity Cycling Session; Behavioral
Lead sponsor: University of Wisconsin, River Falls; Other
Eligibility: 18 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: River Falls, Wisconsin

Conditions: Suicide
Interventions: CLASP-A intervention, Treatment as Usual; Behavioral · Other
Lead sponsor: Brown University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
Interventions: alemtuzumab, cyclosporine, fludarabine phosphate, melphalan, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Up to 70 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2009
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Effects of Games on Memory Reconsolidation and Trauma Symptoms

Telephone Calls for Health for Homebound Older Adults

Intranasal Insulin for the Treatment of HAND

Attention Training on Smartphones

SELUTION4BTK Trial

NDT Effectiveness Study

Antiorbital Calcium in Chronic Conditions

Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Transformative Research in Diabetic Nephropathy 2.0

Distracting Through Procedural Pain and Distress

Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery

Effects of Bone Graft Placement at Implant Installation on Buccal Plate Stability

Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD

UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT Survivors

Detecting Circulating Emboli in Patients with Acute Venous Thromboembolism

Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia

Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects

A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer

Diet, Metabolic Health, and Exercise Responses

Coping Long Term With Attempted Suicide - Adolescents

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer